0001415889-23-012417.txt : 20230818
0001415889-23-012417.hdr.sgml : 20230818
20230818204007
ACCESSION NUMBER: 0001415889-23-012417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230816
FILED AS OF DATE: 20230818
DATE AS OF CHANGE: 20230818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frankenfield Christopher James
CENTRAL INDEX KEY: 0001988344
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 231187103
MAIL ADDRESS:
STREET 1: C/O XILIO THERAPEUTICS, INC.
STREET 2: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-08182023_080801.xml
X0508
4
2023-08-16
0001840233
Xilio Therapeutics, Inc.
XLO
0001988344
Frankenfield Christopher James
828 WINTER STREET, SUITE 300
WALTHAM
MA
02451
false
true
false
false
CHIEF OPERATING OFFICER
0
Stock Option (right to buy)
2.785
2023-08-16
4
A
0
300000
0
A
2033-08-15
Common Stock
300000
300000
D
The option award was granted on August 16, 2023 and shall vest with respect to 1/3 of the shares of common stock underlying the stock option on the first anniversary of the grant date and with respect to the remaining 2/3 of the shares of common stock underlying the stock option on the second anniversary of the grant date.
/s/ Kevin Brennan, Attorney-in-Fact
2023-08-18